This is a StreetInsider.com Premium Only Page

Dynavax (DVAX) – StreetInsider.com Reports

Nov 3, 2023 06:44 AM Dynavax Technologies (DVAX) PT Raised to $28 at H.C. Wainwright

Nov 2, 2023 04:20 PM Dynavax (DVAX) Tops Q3 EPS by 14c; Offers FY23 Revenue Guidance

Aug 4, 2023 03:28 AM Dynavax Technologies (DVAX) PT Raised to $25 at JMP Securities

Aug 3, 2023 05:53 PM Dynavax (DVAX) Files Mixed Shelf

Aug 3, 2023 04:37 PM Dynavax (DVAX) Tops Q2 EPS by 12c ; Offers Guidance

May 3, 2023 03:42 AM Dynavax Technologies (DVAX) PT Lowered to $24 at JMP Securities

May 2, 2023 04:13 PM Dynavax (DVAX) Misses Q1 EPS by 5c

Feb 28, 2023 08:15 AM Dynavax (DVAX) Announces Great Britain Marketing Authorization for HEPLISAV B

Feb 24, 2023 06:53 AM Dynavax Technologies (DVAX) PT Lowered to $27 at H.C. Wainwright

Feb 24, 2023 05:59 AM Dynavax Technologies (DVAX) PT Lowered to $18 at Goldman Sachs

Feb 24, 2023 02:31 AM Dynavax Technologies (DVAX) PT Raised to $25 at JMP Securities

Feb 23, 2023 04:14 PM Dynavax (DVAX) Tops Q4 EPS by 4c

Jan 9, 2023 08:14 AM Dynavax (DVAX) Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results

Nov 4, 2022 06:28 AM Dynavax Technologies (DVAX) PT Lowered to $21 at Goldman Sachs

Sep 27, 2022 04:41 AM UPDATE: JMP Securities Starts Dynavax Technologies (DVAX) at Market Outperform

Aug 5, 2022 03:38 AM Dynavax Technologies (DVAX) PT Lowered to $24 at Goldman Sachs

Aug 4, 2022 04:06 PM Dynavax (DVAX) Tops Q2 EPS by 64c

Jul 13, 2022 02:47 AM Increasing unusual call option volume: GOEV DVAX LZ EGO SRG BZUN

Jun 27, 2022 06:06 AM Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster

Jun 24, 2022 12:00 PM Valneva (VALN) Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

Jun 10, 2022 12:30 PM Valneva SE (VALN) Provides Update on European Inactivated, Whole-Virus COVID-19 Vaccine Program VLA2001

May 19, 2022 05:41 AM Valneva SE (VALN) Announces EMA Acceptance of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate

May 16, 2022 05:17 AM Valneva SE's (VALN) COVID-19 Vaccine Granted Emergency Use Authorization in UAE

May 12, 2022 05:23 PM Independence Realty Trust (IRT) Set to Join S&P MidCap 400; Alpha and Omega Semiconductor (AOSL) & Dynavax Technologies (DVAX) to Join S&P SmallCap 600

May 5, 2022 04:25 PM Dynavax (DVAX) Misses Q1 EPS by 2c

Apr 25, 2022 05:20 AM Valneva SE (VALN) Reports EMA Requested Additional Data for VLA2001

Apr 14, 2022 06:50 AM Valneva SE (VALN) Granted Conditional Marketing Authorization for its Inactivated COVID-19 Vaccine in the UK

Apr 11, 2022 02:40 AM Increasing unusual put option volume: ATER DVAX FEZ SIRI BBD

Mar 17, 2022 07:03 AM Clover’s COVID-19 Vaccine Candidate Demonstrates Durable High Protection and Immune Responses Against Omicron as a Booster (DVAX)

Mar 11, 2022 05:45 AM Valneva SE (VALN) Receives Additional CHMP Questions on its COVID-19 Vaccine Candidate

Mar 1, 2022 07:41 AM UPDATE: Dynavax Technologies (DVAX) PT Lowered to $31 at Goldman Sachs

Mar 1, 2022 05:55 AM Valneva SE (VALN) Granted Emergency Use Authorization from Bahrain for its Inactivated COVID-19 Vaccine VLA2001

Mar 1, 2022 04:32 AM Dynavax Technologies (DVAX) PT Lowered to $20 at Evercore ISI

Feb 28, 2022 04:05 PM Dynavax (DVAX) Tops Q4 EPS by 11c

Feb 25, 2022 01:58 AM Dynavax (DVAX) Receives a List of Questions from CHMP Regarding its COVID-19 Vaccine Candidate VLA2001

Jan 6, 2022 09:25 AM Pre-Open Stock Movers 01/06: (MGTA) (SLGC) (BBBY) Higher; (BLI) (STRO) (WU) Lower (more...)

Jan 5, 2022 05:48 PM After-Hours Stock Movers 01/05: (SLGC) (MGTA) (BNTX) Higher; (BLI) (STRO) (HEAR) Lower (more...)

Jan 5, 2022 04:45 PM Goldman Sachs Reinstates Dynavax Technologies (DVAX) at Buy

Dec 29, 2021 06:33 AM Dynavax Technologies (DVAX) PT Raised to $28 at H.C. Wainwright

Dec 28, 2021 11:44 AM Dynavax (DVAX) Announces Indian Approval of COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant

Dec 14, 2021 08:10 AM Dynavax (DVAX) Appoints Elaine D. Sun to its Board

Dec 8, 2021 05:41 AM Dynavax (DVAX) Announces Advance Purchase Agreement with Bahrain for 1M Doses of VLA2001 COVID-19 Vaccine

Nov 26, 2021 12:15 PM Dynavax (DVAX) on Watch as Partner Clover Starts Phase 2 Trial of COVID-19 Vaccine Booster

Nov 10, 2021 06:28 AM Valneva (VALN) Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001

Nov 5, 2021 06:45 AM Dynavax Technologies (DVAX) PT Raised to $30 at Cowen

Nov 4, 2021 05:31 PM Dynavax (DVAX) Reports Q3 Loss of $0.24/sh

Oct 21, 2021 04:23 PM Dynavax (DVAX) Appoints Scott Myers as Board Chair

Oct 18, 2021 05:33 AM Dynavax (DVAX) Announces Valneva's COVID-19 Vaccine Developed Using Dynavax's CpG 1018 Adjuvant Meets Both Co-Primary Endpoints in Phase 3 Trial

Oct 18, 2021 05:31 AM Valneva (VALN) Reports Positive Phase 3 Results for VLA2001, Inactivated, Adjuvanted COVID-19 Vaccine Candidate

Oct 4, 2021 08:04 AM Dynavax (DVAX) and U.S. Department of Defense Announce Collaboration to Develop an Adjuvanted Plague Vaccine Using Dynavax's CpG 1018 Adjuvant